Noveris Health Sciences Inc. (CNSX: NVRS)
Health Care · Pharmaceuticals · CA
CA$0.07
-12.50% today · -86.0% 1Y
Noveris Health Sciences Inc. (CNSX: NVRS) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $2.87M.
Over the last twelve months the share price has lost 86.0%, trading between 0.07 and 3.00.
Tweenvest scores Noveris Health Sciences Inc. across four factors: quality 17/100, value 46/100. Its strongest factor is value.
NVRS price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.87M
- Revenue (TTM)
- —
- P/E
- 0.82
- EPS
- 0.09
- Dividend yield
- —
- Beta (5Y)
- -5.51
- 52-week high
- CA$3.00
- 52-week low
- CA$0.07
- Avg volume (3M)
- —
- Shares outstanding
- 58.55M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Medicamen Organics LimitedNSEI: MEDIORG | $2.94M | Rs23.35 | -4.89% |
| Nextgen Biomed LtdTASE: NXGN-M | $2.93M | ₪— | — |
| Gujarat Terce Laboratories LimitedBSE: 524314 | $2.91M | Rs36.20 | +2.96% |
| Invion LimitedASX: IVX | $2.90M | AU$0.04 | -2.56% |
| Eastgate Biotech Corp.OTCPK: ETBI | $2.86M | $0.00 | -46.00% |
| SOHM, Inc.OTCPK: SHMN | $2.81M | $0.00 | +7.78% |
| Clearmind Medicine Inc.NasdaqCM: CMND | $2.77M | $6.61 | +0.46% |
| Lasa Supergenerics LimitedNSEI: LASA | $2.77M | Rs5.32 | -5.00% |
Figures last refreshed Oct 11, 2026.